sleekOptions,True,2019-02-12 15:59:00,40.553,GSK Last two months 12 winners and 2 losers
Sunnybahamas,True,2019-02-12 15:26:00,40.59,GSK GILD HIV empire 53B in revenues per Q in 2019 alone 42B in 2018 FY GILD is the undisputed king of HIV WW
Sunnybahamas,True,2019-02-12 15:15:00,40.581,GILD GSK Biktarvy over 12B a quarter by EOY in 2019 Genvoya over 12B WW as well 4B alone n 2019 Truvada over 1B a Q bonus n 2019
risenhoover,,2019-02-12 14:39:00,40.569,GSK GlaxoSmithKline files form 6K httpsfinteliosusgsk
risenhoover,,2019-02-12 12:33:00,40.462,GSK GlaxoSmithKline files form 6K httpsfinteliosusgsk
cctranscripts,,2019-02-12 11:40:00,40.364,Report of foreign issuer Rules 13a16 and 15d16 conferencecalltranscriptso GSK
cctranscripts,,2019-02-12 11:15:00,40.401,Report of foreign issuer Rules 13a16 and 15d16 conferencecalltranscriptso GSK
Sunnybahamas,True,2019-02-12 10:41:00,40.325,GILD GSK Biktarvy and Genvoya will be the best selling HIV in EU knocking VIIV into inferiors Genvoya already 1
